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Introduction
When a woman presents with abnormal uterine 
bleeding, her history is taken and further tests are 
then considered (Dreisler et al., 2013; Bignardi et 
al., 2009; NICE guideline 44, 2007). Risk factors 
for uterine intracavitary pathology in general, and 
endometrial cancer in particular, include post­
menopausal status, advanced age and oestrogen 
exposure e.g. due to anovulation, obesity, late 
menopause or unopposed oestrogen use (Amant et 
al., 2005; Bignardi et al., 2009; Van den Bosch et 
al., 2012). 
In the large majority of women, abnormal 
bleeding is caused by benign lesions such as an 
endometrial polyp or an intracavitary fibroid (Van 
den Bosch et al., 1995; Werbrouck et al., 2011, 
NICE guideline 44, 2007). These lesions are not 
life­threatening but these women expect their 
bleeding problem to be solved. In postmenopausal 
women endometrial thickness measurement at 
unenhanced transvaginal ultrasound examination 
(UTVS) is used to triage patients at high risk for 
endometrial cancer (Smith­Bindman et al., 1998; 
Dijkhuizen et al., 2000; Gupta et al., 2002; Tabor et 
al., 2002; Epstein et al., 2004; Clark et al., 2006; 
Timmermans et al., 2010). A regular and thin endo­
metrium is reassuring, and a thick endometrium 
warrants further investigation (Van den Bosch et al., 
2007; Bignardi et al., 2009). 
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Abstract
Objectives: Our primary aim was to assess how patients’ characteristics, bleeding pattern, sonographic endometrial 
thickness (ET) and additional features at unenhanced ultrasound examination (UTVS) and at fluid instillation 
sonography (FIS) contribute to the diagnosis of intracavitary uterine pathology in women presenting with abnormal 
uterine bleeding (AUB). We further aimed to report the prevalence of pathology in women presenting with AUB. 
Methods: 1220 consecutive women presenting with AUB underwent UTVS, colour Doppler imaging (CDI) and 
FIS. Most women (n = 1042) had histological diagnosis. Results: Mean age was 50 years and 37% were post­
menopausal. Of 1220 women 54% were normal, polyps were diagnosed in 26%, intracavitary fibroids in 11%, 
hyperplasia without atypia in 4% and cancer in 3%. All cancers were diagnosed in postmenopausal (7%) or 
perimeno pausal (1%) women. ET had a low predictive value in premenopausal women (LR+ and LR­ of 1.34 and 
0.74, respectively), while FIS had a LR+ and LR­ of 6.20 and 0.24, respectively. After menopause, ET outperformed 
all patient characteristics for the prediction of endometrial pathology (LR+ and LR­ of 3.13 and 0.24). The 
corresponding LR+ and LR­ were 10.85 and 0.71 for CDI and 8.23 and 0.26 for FIS.
Conclusion: About half of the women presenting to a bleeding clinic will have pathology. In premenopausal women, 
benign lesions are often the cause of AUB. For the prediction of intracavitary pathology ET is of little value in 
premenopausal women. CDI and FIS substantially improve the diagnostic accuracy.
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machine equipped with a 6­12MHz 3D endovaginal 
probe thereafter. At UTVS following variables were 
recorded: maximal total endometrial thickness in 
sagittal plane (Leone et al., 2010), the endometrial 
pattern (presence or absence of a 3­layer pattern), 
presence of focal intracavitary lesions, type of 
intracavitary lesion (polyp, fibroid) if present, 
presence or absence of fibroids (number) elsewhere 
in the uterus, presence of vascularity within the 
endo metrium. Immediately after UTVS, all patients 
underwent FIS using saline in the first 402 cases and 
gel (EndosgelTM, Farco­Pharma GmbH, Köln, 
Germany) in the remaining cases (Werbrouck et al., 
2011). FIS was not performed in 13 cases because 
of the presence of pre-existing intracavitary fluid 
(n = 10), vaginal stenosis (n = 2), a high level of 
suspicion for malignancy (n = 1), and because of 
technical failure in 34 cases (2.8%). The following 
variables were recorded at FIS: total endometrial 
thickness (sum of both single layers measured in 
sagittal plane), presence of an intracavitary lesion, 
type of intracavitary lesion (polyp, fibroid, polypoid 
endometrium). The endometrium is defined as 
polypoid in case of multiple deep indentations 
(Leone et al., 2010). Subsequently most women 
(n = 1042) underwent diagnostic hysteroscopy, 
endometrial sampling, operative hysteroscopy or 
hysterectomy. In cases where there were multiple 
intracavitary lesions a single outcome was allocated 
to each woman according to the following diagnostic 
hierarchy: cancer, atypical hyperplasia, polyp, 
fibroid, hyperplasia without atypia. In reporting the 
prevalence of pathology for all patients presenting at 
the bleeding clinic (Table I), the 176 cases without 
available histology were also included. The diag­
nosis of the latter was based on FIS (polyp, intra­
cavitary fibroid, atrophy defined as an ET < 5mm, pro-
liferative/secretory endometrium as an ET ≥ 5mm).
The primary aim of this study was to evaluate the 
importance of patients’ demographic characteristics, 
bleeding pattern, endometrial thickness and addi­
tional ultrasound features at UTVS and at fluid 
instillation sonography (FIS) for the diagnosis of 
intracavitary uterine pathology in pre­ and post­
menopausal women presenting with abnormal 
uterine bleeding.
The secondary aim of the study is to evaluate 
the prevalence of pathology in women presenting 
with abnormal uterine bleeding before and after 
menopause.
Methods
Unenhanced transvaginal sonography (UTVS) with 
colour Doppler imaging (CDI) followed by fluid 
instillation sonography (FIS) was performed in 
1220 consecutive women presenting with abnormal 
uterine bleeding at the Leuven Bleeding Clinic from 
October 2004 till December 2010. A medical history 
was taken including the following variables: age, 
menopausal status, weight, height, body mass index 
(BMI), parity, gravidity, use of hormonal therapy, 
type of hormonal therapy, bleeding pattern (cyclical, 
non­cyclical or both cyclical and non­cyclical), 
amount of bleeding (spotting, ‘normal’ menses, 
more than ‘normal’ menses), and duration of the 
bleeding problem. Menopause was defined as the 
absence of menstruation for at least 12 months in a 
woman older than 40, after exclusion of pregnancy. 
If the menopausal status was uncertain, the woman 
was classified as perimenopausal. All ultrasound 
examinations were performed by the first author 
using an Acuson SequoiaTM 512 (Siemens, Erlangen, 
Germany) equipped with an EV­8C4 endovaginal 
probe in the first 402 cases and a GE VolusonTM E8 
(GE Healthcare, Milwaukee, WI, USA) ultrasound 
Table I. — Final diagnosis in the total group, and in the pre­, peri­ and post­menopausal group.
Pre­menopausal Peri­menopausal Post­menopausal Total
N % N % N % N %
Proliferative/Secretory 344 51.3 42 45.2 66 14.5 452 37.1
Hypotrophy/atrophy 47 7.0 15 16.1 140 30.8 202 16.6
Hyperplasia without atypia 35 5.2 4 4.3 9 2.0 48 3.9
Polyp 123 18.4 18 19.4 171 37.7 313 25.7
Fibroid 95 14.2 11 11.8 28 6.2 134 11.0
Atypical hyperplasia 0 0 0 0 1 0.2 1 0.1
Carcinoma 0 0 1 1.1 30 6.6 31 2.5
Other 26 3.9 1 1.1 9 2.0 36 3.0
Total 670 100 93 100 454 100 1217 100
In the 176 cases without available histology the diagnosis was based on FIS: atrophy (defined as an ET < 5mm) in 54, 
proliferative/secretory endometrium (defined as an ET ≥5mm) in 76, polyps in 24, an intracavitary fibroid in 15, miscellaneous 
in 7.
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postmenopausal group), there were 313 (25.7%) 
cases of polyps, 134 (11%) intracavitary fibroids, 
48 (3.9%) cases of endometrial hyperplasia without 
atypia, 1 (0.1%) with atypia and 31 (2.5%) endo­
metrial cancers. Cancer was diagnosed in 7% of 
postmenopausal women and 1% of perimenopausal 
patients. There were no cancers in premenopausal 
women. Polyps were diagnosed in 18.4% of pre­
menopausal versus 37.7% of postmenopausal 
women, and intracavitary fibroids in 14.2% and 
6.2%, respectively. Endometrial hyperplasia without 
atypia was diagnosed in 5.2% of women of 
reproductive age, in 4.3% of perimenopausal women 
and in 2% after menopause. The median ET at 
UTVS in cancer cases was 16.8 mm (range 3.3 mm­
78.9 mm) and in 6 cases the endometrium was not 
measurable at UTVS. In 3 cases of cancer the 
reported ET at UTVS was ≤ 5 mm (4.8 mm, 4.8 mm 
and 3.3 mm, respectively). However, in all three 
cases possible intracavitary pathology had been 
suggested based on the irregularity of the endo­
metrium at FIS in two cases and because of 
incomplete visualization due to fibroids in the 
third patient (Fig. 1). According to the International 
In order to evaluate the relative importance of the 
different variables for the prediction of intracavitary 
pathology, models were designed using stepwise 
variable selection. 
All statistical analyses were performed with SAS 
9.3 (SAS Institute Inc., Cary, NC, USA.) The area 
under the ROC curve (AUC) and its 95% confidence 
interval were calculated for each model.
Results
The mean age was 50 years (range 19­86), with an 
average parity of 1.9 (range 0­12) and a body mass 
index ranging from 16 to 63 (mean 26). Three 
patients with incomplete data were excluded from 
further analysis (1217 cases included). Four hundred 
and fifty-five patients (37.3%) were postmeno-
pausal, 672 (55.1%) premenopausal and 93 (7.6%) 
were classified as perimenopausal. The endometrial 
thickness was not measureable at UTVS in 139 
cases (11%). The final diagnosis for all patients 
presenting at the bleeding clinic is summarized in 
Table I: of 1217 women 654 (54%) were normal 
(59% of the premenopausal women and 44% of the 
Fig. 1. — Images at unenhanced ultrasound (UTVS) and at fluid 
instillation sonography (FIS) (for case 1 and 2) of endometrial 
cancer with an endometrial thickness < 5 mm: FIS demonstrates 
an irregular lesion in case 1 and 2 (in case 1 it is associated with 
visible vascularity within the irregularity). 
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For the prediction of focal intracavitary lesions in 
premenopausal women, patient’s age was selected 
as the single most relevant patient characteristic, 
although the predictive value was low (AUC 0.61; 
95% CI 0.56­0.66). Measurements of ET at UTVS 
did not significantly improve prediction (AUC 0.64; 
95% CI 0.59­0.69) in the premenopausal group. 
In postmenopausal women, age and BMI were 
selected as the most important patient’s charac­
teristics for predicting cancer (AUC 0.72; 95% CI 
0.61­0.82) and focal benign lesions (AUC 0.60; 
95% CI 0.54­0.66). If ET was included in the 
analysis together with patient’s characteristics, ET 
was selected as the only relevant predictive factor 
for both endometrial cancer (AUC 0.80; 95% CI 
0.72­0.89) and benign focal intracavitary lesions 
(AUC 0.80; 95% CI 0.72­0.89) after the menopause. 
The diagnostic accuracy for intracavitary 
pathology using both UTVS and FIS is summarized 
in Table II for premenopausal and Table III for 
postmenopausal women. 
In premenopausal women, the LR+ and LR­ for 
intracavitary uterine pathology was 1.34 and 0.74 
Endometrial Tumor Analysis (IETA)­recommen­
dations (Leone et al., 2010) the endometrium in the 
latter case should have been reported as “not 
measurable”.
Uterine fibroids outside the endometrial cavity were 
reported in 27% of patients at UTVS: in 29% of 
premenopausal women and 23% of women after 
menopause (Fig. 2). In the majority of women in 
whom fibroids had been reported on UTVS, 
intracavitary pathology was also present: endo­
metrial hyperplasia in 4%, endometrial cancer in 
2%, polyps in 23% and intracavitary fibroids in 
32%. In the premenopausal group with fibroids at 
UTVS, hyperplasia, polyps and intracavitary 
fibroids were detected in 5%, 16% and 41%, 
respectively (Fig. 2a). In postmenopausal women 
with fibroids reported at UTVS, hyperplasia, 
endometrial cancer, polyps and intracavitary 
fibroids were diagnosed in 3%, 6%, 38% and 14%, 
respectively (Fig. 2b). Intramural or subserous 
fibroids were the only structural pathology in 10% 
of cases (124/1220) of the total group: 11% and 9% 
in pre­ and postmenopausal women, respectively.
Fig. 2. — Incidence of intracavitary pathology in patients with uterine fibroids recorded at UTVS: (a) premenopausal group; 
(b) postmenopausal group.
2a: PRE-menopausal women: fibroids were recorded in 197 (29%) women. In 19 of the 32 polyp cases (59%) and in 55 of the 
81 intracavitary fibroid cases (68%) the intracavitary lesion had already been suspected at UTVS.
2b: POST-menopausal women: fibroids were recorded in 105 (23%) women. In 23 of the 40 polyp cases (58%) and in 7 of the 
15 intracavitary fibroid cases (47%) the intracavitary lesion had already been suspected at UTVS.
a
b
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shows high negative predictive values, ranging from 
94 to 100% but very low positive predictive values 
ranging from 9 to 19%.
In postmenopausal women the best model 
predicting endometrial cancer included the presence 
of one or more vessels within the endometrium 
using colour Doppler imaging, endometrial thick­
ness and a polypoid endometrial pattern at FIS: 
AUC 0.84 (0.76­0.92). For the prediction of benign 
focal lesions (endometrial polyps and intracavitary 
fibroids), age, endometrial thickness, the presence of 
a lesion at FIS and a polypoid endometrial pattern at 
FIS were the selected variables: AUC 0.90 (0.86­
0.94).
respectively for ET at UTVS using a cut­off of 
9 mm, 6.63 and 0.74 for the presence of one or more 
dominant vessels at CDI and 6.20 and 0.24 for FIS. 
In postmenopausal women the corresponding LR+ 
and LR­ were 3.13 and 0.24 for ET using a cut­off 
of 5 mm, 10.85 and 0.71 for CDI and 8.23 and 0.26 
for FIS. In premenopausal women, the retained 
variables predicting intracavitary pathology at 
multivariate analysis were age, fibroids at UTVS, a 
polypoid endometrial pattern at FIS (inverse 
association) and the presence of a lesion seen at 
FIS: model with an AUC of 0.88 (0.85­0.92). The 
diagnostic accuracy of UTVS, CDI and FIS for 
endometrial cancer is summarized in Table IV, and 
Table II. — Unenhanced transvaginal ultrasound (UTVS), color Doppler imaging (CDI) and fluid instillation sonography 
(FIS) for the diagnosis of intracavitary pathology* in premenopausal women.
PREmenopausal Sens Spec PPV NPV LR+ LR-
UTVS % % % %
Endometrial thickness
> 3mm
> 4mm
> 5mm
Optimal (> 9 mm)
95
93
86
57
5
12
20
58
38
39
40
45
65
73
71
69
1.01
1.05
1.09
1.34
0.87
0.62
0.29
0.74
Focal lesion 44 94 81 72 6.81 0.60
CDI
Vessel(s) within the endometrium 29 96 81 68 6.63 0.74
FIS
Lesion 79 87 80 87 6.20 0.24
Sens = sensitivity; spec = specificity; PPV = positive predictive value; NPV = negative predictive value; 
LR+ = positive likelihood ratio; LR­ = negative likelihood ratio.
* Endometrial polyps and intracavitary fibroids.
Table III. — Unenhanced ultrasound (UTVS), color Doppler imaging (CD) and fluid instillation sonography (FIS) for 
the diagnosis of intracavitary pathology* in postmenopausal women.
POSTmenopausal Sens Spec PPV NPV LR+ LR-
UTVS % % % %
Endometrial thickness
> 3mm
> 4mm
> 5mm
Optimal (> 5 mm)
93
90
83
83
45
64
74
74
74
81
84
84
79
79
72
72
1.68
2.48
3.13
3.13
0.16
0.16
0.24
0.24
Focal lesion 39 95 93 49 7.86 0.64
CDI
Vessel(s) within the endometrium 31 97 95 46 10.85 0.71
FIS
Lesion 76 91 93 70 8.23 0.26
Sens = sensitivity; spec = specificity; PPV = positive predictive value; NPV = negative predictive value; 
LR+ = positive likelihood ratio; LR­ =negative likelihood ratio.
* Endometrial polyps, intracavitary fibroids and endometrial cancer.
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The fact that 10% of cancer cases were below the 
5mm ET threshold is unexpectedly high and may be 
due to a selection bias: easier to diagnose cancer 
were more likely to have been picked up prior to 
referral to the bleeding clinic, resulting in a higher 
prevalence of difficult cases with endometria that 
are hard to visualize at ultrasound examination. It is 
also important to acknowledge that our results 
should not be extrapolated to an asymptomatic 
population (Menzies et al., 2011; Worley et al., 
2011; Breijer et al., 2012). The fact that part of the 
fluid instillations was performed with saline and the 
other with gel could have influenced the results. 
However this issue has been addressed in a 
publication analysing two consecutive cohorts of 
402 women undergoing SIS or GIS and showing a 
comparable diagnostic accuracy in both groups 
(Werbrouck et al., 2011).
After menopausal status, age was the most 
relevant patient’s characteristic. In premenopausal 
women, focal intracavitary lesions (fibroids and 
polyps) become more prevalent with advancing age. 
After the menopause, endometrial cancer risk also 
increases with advancing age, a finding which is 
concordant with previous reports (Van den Bosch 
et al., 1996; Prudie & Green, 2001; Amant et al., 
2005). 
An endometrial thickness measurement should be 
reported at every ultrasound examination (Leone et 
al., 2010). However, in premenopausal women, 
because of cyclical endometrial changes, ET is less 
reliable for the detection of pathology. This is 
illustrated by the fact that ET measurement at UTVS 
did not improve the predictive value for intracavitary 
lesions in premenopausal women. In postmenopausal 
women, in general a thin endometrium rules out 
Discussion
We have shown that, other than menopausal status, 
the knowledge of a patient’s history is of little value 
for predicting the presence or absence of intracavitary 
pathology in women with abnormal bleeding. We 
have also shown that benign focal intracavitary 
lesions are present in one third of premenopausal 
women and in almost half of postmenopausal 
women with abnormal uterine bleeding. After the 
menopause, our data support the use of measurements 
of ET at UTVS as the cornerstone for diagnosing of 
intracavitary pathology, whereas ET measurements 
are of no value in premenopausal women. Finally, 
our study confirms the importance of CDI and FIS 
for the diagnosis of intracavitary pathology in both 
pre­ and postmenopausal women (Dijkhuizen et al., 
2000; de Kroon et al., 2003; Timmerman et al., 
2003; Opolskiene et al., 2011).
The strengths of this study are the prospective 
design, the large number of consecutive women 
included and the fact that FIS, hysteroscopy and 
endometrial sampling were performed in the vast 
majority of patients. The fact that the study was 
carried out in a single centre by one operator may be 
seen as a strength in terms of the protocol being 
applied reproducibly within the trial, but may 
also be a weakness as the results may be less 
generalizable. We acknowledge that the prevalence 
of pathology may vary between centres, some 
reporting higher malignancy rates (Amant et al., 
2005; Opolskiene et al., 2011). Our lower prevalence 
of cancer may be explained by some being diagnosed 
as emergencies on biopsies carried out in the general 
outpatient clinic, in which case the patient would not 
have attended the bleeding clinic at our hospital. 
Table IV. — Unenhanced ultrasound (UTVS), color Doppler imaging (CD) and fluid instillation sonography (FIS) 
for the diagnosis of endometrial cancer in postmenopausal women. 
POSTmenopausal Sens Spec PPV NPV LR+ LR-
UTVS % % % %
Endometrial thickness
> 3mm
> 4mm
> 5mm
100
96
88
23
32
40
9
10
11
100
99
98
1.29
1.41
1.47
0
0.13
0.31
Lesion 50 76 15 94 2.07 0.67
CDI
Vessel(s) within the endometrium 47 82 19 95 2.59 0.65
FIS
Lesion 70 51 11 95 1.42 0.59
Sens = sensitivity; spec = specificity; PPV = positive predictive value; NPV = negative predictive value; 
LR+ = positive likelihood ratio; LR­ =negative likelihood ratio.
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to false negative results as reflected by the sub-
optimal LR­ both in pre­ and postmenopausal 
women (Table II and III).
When carrying out FIS, the fluid instilled into the 
uterine cavity offers a negative contrast facilitating 
the visualization of the endometrial lining at 
ultrasound examination. FIS has demonstrated a 
diagnostic reliability for endometrial polyps and 
intracavitary fibroids that is comparable to 
hysteroscopy (de Kroon et al., 2003; Dijkhuizen et 
al., 2000).
In our series intramural or subserosal fibroids 
without associated intracavitary pathology were 
reported in 10% of cases. Other pathology such as 
endometrial atrophy or ovulatory dysfunction could 
be responsible for the abnormal bleeding in some of 
these women, suggesting the limited clinical 
relevance of diagnosing extra-cavitary fibroids. 
However, finding a fibroid does not lower the 
likelihood of endometrial cancer. In our series about 
1 in 5 endometrial cancer cases also had uterine 
fibroids. Especially in postmenopausal women, 
conservative treatment including myomectomy, 
myoma morcellation, uterine artery embolization or 
endometrial ablation (NICE guideline 44, 2007) 
should be considered only after malignancy has 
been excluded.
In summary, our study demonstrates that, other 
than menopausal status, other patient characteristics 
have a limited value in the diagnosis of intracavitary 
intracavitary uterine pathology, and is particularly 
effective at excluding the presence of cancer.
Cut­off values for total endometrial thickness 
between 3 and 5 mm have been proposed to define 
the presence or absence of an increased risk of 
endometrial malignancy, but these are only valid if 
the endometrium is clearly visible throughout the 
cavity. The fact that about one in five cancer cases 
did not show a clearly visible endometrium on 
UTVS in our study confirms that if the endometrium 
is not measurable, it should be considered abnormal 
until proven otherwise (Van den Bosch et al., 2007; 
Leone et al., 2010). We believe that FIS is indicated 
in all women with postmenopausal bleeding if the 
entire endometrium cannot be visualized clearly. 
Colour Doppler imaging enables the visualization 
of vessels within the endometrium. In endometrial 
polyps the ‘pedicle artery sign’ (Timmerman et al., 
2003) is often visible using CDI (Fig. 3), a fibroid 
often shows circumferential vascularization (Fig. 4), 
and the visualization of one or more dominant 
vessels within the endometrium with CDI is 
commonly associated with endometrial cancer 
(Opolskiene et al., 2011). In our study increased 
vascularity was reported in half of the cancer cases 
and in one third of the patients with focal 
intracavitary lesions. Small vessels may not be 
detected with CDI and transient myometrial 
contractions may result in an intermittent absence 
of flow signals (Van den Bosch et al., 2002), leading 
Fig. 3. — Endometrial polyp (gel instillation sonography at 
grey scale and power Doppler imaging): note the pedicle artery.
Fig. 4. — Intracavitary fibroid with circumferential vascu-
larization (gel instillation sonography at grey scale and power 
Doppler imaging).
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artery sign based on sonography with color Doppler imaging 
can replace second­stage tests in women with abnormal 
vaginal bleeding. Ultrasound Obstet Gynecol. 2003;22:166­
71.
Timmermans A, Opmeer B, Khan K et al. Endometrial thickness 
measurement for detecting endometrial cancer in women 
with postmenopausal bleeding: a systematic review and 
meta­analysis. Obstet Gynecol. 2010;116:160­7.
Van den Bosch T, Coosemans A, Morina M et al. Screening for 
uterine tumours. Best Pract Res Clin Obstet Gynaecol. 2012; 
26:257­66.
Van den Bosch T, Van Schoubroeck D, Vergote I et al. A thin 
and regular endometrium on ultrasound is very unlikely in 
patients with endometrial malignancy. Ultrasound Obstet 
Gynecol. 2007;29:674­9.
Van den Bosch T, Van Schoubroeck D, Lu C et al. Color 
Doppler and gray­scale ultrasound evaluation of the post­
partum uterus. Ultrasound Obstet Gynecol. 2002;20:586­91.
Van den Bosch T, Vandendael A, Van Schoubroeck D et al. 
Age, weight, body mass index and endometrial thickness in 
postmenopausal women. Acta Obstet Gynecol Scand. 
1996;75:181­2.
Van den Bosch T, Vandendael A, Van Schoubroeck D et al. 
Combining vaginal ultrasonography and office endometrial 
sampling in the diagnosis of endometrial disease in 
postmenopausal women. Obstet Gynecol. 1995;85:349­52.
Werbrouck E, Veldman J, Luts J et al. Detection of endometrial 
pathology using saline infusion sonography versus gel 
instillation sonography: a prospective cohort study. Fertil 
Steril. 2011;95:285­8.
Worley MJ Jr, Dean KL, Lin SN et al. The significance of a 
thickened endometrial echo in asymptomatic postmenopausal 
patients. Maturitas. 2011;68:179­81. 
pathology. Moreover, we showed the lack of 
relevance of endometrial thickness measurements in 
premenopausal women. Benign focal intracavitary 
lesions are the most likely structural cause of 
abnormal uterine bleeding in all age groups. Some 
of those lesions may remain unnoticed on UTVS 
and fluid instillation sonography should therefore be 
considered in case of abnormal uterine bleeding.
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